12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok
12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok
12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy. Ann Oncol.<br />
1999;10:1293-9<br />
Kiss TL, Mollee P, Lazarus HM, Lipton JH. Stem cell transplantation <strong>for</strong> mantle cell lymphoma: if, when and<br />
how? Bone Marrow Transplant. 2005 Oct;36(8):655-61. Review.<br />
Laudi N, Arora M, Burns L, et al. Efficacy of High-dose therapy and hematopoietic stem cell transplantation <strong>for</strong><br />
mantle cell lymphoma. Am J Hem 2006, 81: 519-24.<br />
Popplewell LL, Nademanee A, Carter N et al. Autologous or allogeneic cell transplantation <strong>for</strong> mantle cell<br />
lymphoma (MCL): outcomes over a 10-year period at City of Hope. 2004 ASH abstract 255.<br />
Rifkind J, Mollee P, Messner HA, Lipton JH. Allogeneic stem cell transplantation <strong>for</strong> mantle cell lymphoma--does<br />
it deserve a better look? Leuk Lymphoma. 2005 Feb;46(2):217-23..<br />
Vandenberghe E, Ruiz de Elvira C, Isaacson P et al. Does transplantation improve survival in mantle cell<br />
lymphoma (MCL)?: a study by the EBMT. 2000, ASH abstract 482<br />
Non-myeloablativ alloHCT<br />
Gouill SL, Kroeger N, Dhedin N, Nagler A, et al. Interest of non-myeloablative allogeneic stem cell<br />
transplantation in mantle cell lymphoma: A multicenter retrospective study. 2008. ASH abstract 1965.<br />
Maris MB, Sandmaier BM, Storer BE, Chauncey T, Stuart MJ, Maziarz RT, Agura E, Langston AA, Pulsipher M,<br />
Storb R, Maloney DG. Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total<br />
body irradiation <strong>for</strong> relapsed and refractory mantle cell lymphoma. Blood. 2004 Dec 1;104(12):3535-42.<br />
Sorror ML, Storer B, Sandmaier BM, Maris M, et al. Sustained Graft versus lymphoma effect among patients<br />
with mantle cell lymphoma given non-myeloablative hematopoietic cell transplantation. 2008, ASH abstract 2147<br />
Tam CS, Bassett R, Ledesma C, Korbling, et al. Mature results of the M. D. Anderson cancer center risk adapted<br />
transplantation strategy in mantle cell lymphoma. Blood. 2009, 113: 4144-52.<br />
Robinson SP, Taghipur G, Canals C, et al. Reduced-intensity allogeneic stem cell transplantation in mantle cell<br />
lymphoma: an update from the EBMT. 2004; ASH abstract 622.<br />
Robinson SP, Sureda A, Canals C, et al. Identification of prognostic factors predicting the outcome of reduced<br />
intensity allogeneic stem cell transplantation in mantle cell lymphoma. An analysis from the lymphoma party of<br />
the EBMT. 2008. ASH abstract 457.<br />
74